Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions

Immunity

Volumn 40, Issue 6, 2014, Pages 989-1001

  DiMeglio, Paola ^a   Duarte, João H ^a   Ahlfors, Helena ^a   Owens, Nick D L ^a   Li, Ying ^a   Villanova, Federica ^b   Tosi, Isabella ^b   Hirota, Keiji ^a,d   Nestle, Frank O ^b   Mrowietz, Ulrich ^c   Gilchrist, Michael J ^a   Stockinger, Brigitta ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CYTOCHROME P450 1A; CYTOCHROME P450 1B1; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; MESSENGER RNA; PROTEIN S100B; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR;

ACANTHOSIS; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; DERMATITIS; DISEASE SEVERITY; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN TISSUE; INFLAMMATION; KERATINOCYTE; MACROPHAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PARAKERATOSIS; PRIORITY JOURNAL; PSORIASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; UPREGULATION; WILD TYPE;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; AZO COMPOUNDS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARBAZOLES; CYTOCHROME P-450 CYP1A1; CYTOKINES; ENVIRONMENTAL EXPOSURE; HUMANS; INFLAMMATION; KERATINOCYTES; MICE; MICE, KNOCKOUT; PSORIASIS; PYRAZOLES; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; SKIN; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84902669022     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.04.019     Document Type: Article

References (51)

1. Austin L.M., Ozawa M., Kikuchi T., Walters I.B., Krueger J.G. The majority of epidermal Tcells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood Tcells in psoriatic patients. J.Invest. Dermatol. 1999, 113:752-759.
2. Bata-Csorgo Z., Szell M. The psoriatic keratinocytes. Expert Rev. Dermatol. 2012, 7:473-481.
3. Bjeldanes L.F., Kim J.Y., Grose K.R., Bartholomew J.C., Bradfield C.A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol invitro and invivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. USA 1991, 88:9543-9547.
4. Bock K.W., Köhle C. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem. Pharmacol. 2006, 72:393-404.
5. Bowcock A.M., Shannon W., Du F., Duncan J., Cao K., Aftergut K., Catier J., Fernandez-Vina M.A., Menter A. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum. Mol. Genet. 2001, 10:1793-1805.
6. Chodaczek G., Papanna V., Zal M.A., Zal T. Body-barrier surveillance by epidermal γδ TCRs. Nat. Immunol. 2012, 13:272-282.
7. Davidovici B.B., Sattar N., Prinz J., Puig L., Emery P., Barker J.N., van de Kerkhof P., Ståhle M., Nestle F.O., Girolomoni G., Krueger J.G. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J.Invest. Dermatol. 2010, 130:1785-1796.
8. Di Cesare A., Di Meglio P., Nestle F.O. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J.Invest. Dermatol. 2009, 129:1339-1350.
9. Di Meglio P., Perera G.K., Nestle F.O. The multitasking organ: recent insights into skin immune function. Immunity 2011, 35:857-869.
10. Duarte J.H., Di Meglio P., Hirota K., Ahlfors H., Stockinger B. Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses invitro and invivo. PLoS ONE 2013, 8:e79819.
11. Fritsche E., Schäfer C., Calles C., Bernsmann T., Bernshausen T., Wurm M., Hübenthal U., Cline J.E., Hajimiragha H., Schroeder P., et al. Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc. Natl. Acad. Sci. USA 2007, 104:8851-8856.
12. Gillner M., Bergman J., Cambillau C., Fernström B., Gustafsson J.A. Interactions of indoles with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Mol. Pharmacol. 1985, 28:357-363.
13. Girardi M., Lewis J.M., Filler R.B., Hayday A.C., Tigelaar R.E. Environmentally responsive and reversible regulation of epidermal barrier function by gammadelta Tcells. J.Invest. Dermatol. 2006, 126:808-814.
14. Gudjonsson J.E., Johnston A., Dyson M., Valdimarsson H., Elder J.T. Mouse models of psoriasis. J.Invest. Dermatol. 2007, 127:1292-1308.
15. Gudjonsson J.E., Ding J., Johnston A., Tejasvi T., Guzman A.M., Nair R.P., Voorhees J.J., Abecasis G.R., Elder J.T. Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with invitro models. J.Invest. Dermatol. 2010, 130:1829-1840.
16. Hahn M.E., Karchner S.I., Evans B.R., Franks D.G., Merson R.R., Lapseritis J.M. Unexpected diversity of aryl hydrocarbon receptors in non-mammalian vertebrates: insights from comparative genomics. J.Exp. Zoolog. A Comp. Exp. Biol. 2006, 305:693-706.
17. Haider A.S., Duculan J., Whynot J.A., Krueger J.G. Increased JunB mRNA and protein expression in psoriasis vulgaris lesions. J.Invest. Dermatol. 2006, 126:912-914.
18. Johnson-Huang L.M., Suárez-Fariñas M., Pierson K.C., Fuentes-Duculan J., Cueto I., Lentini T., Sullivan-Whalen M., Gilleaudeau P., Krueger J.G., Haider A.S., Lowes M.A. A single intradermal injection of IFN-γ induces an inflammatory state in both non-lesional psoriatic and healthy skin. J.Invest. Dermatol. 2012, 132:1177-1187.
19. Kadow S., Jux B., Zahner S.P., Wingerath B., Chmill S., Clausen B.E., Hengstler J., Esser C. Aryl hydrocarbon receptor is critical for homeostasis of invariant gammadelta Tcells in the murine epidermis. J.Immunol. 2011, 187:3104-3110.
20. Karin M., Liu Zg., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 1997, 9:240-246.
21. Katiyar S.K., Matsui M.S., Mukhtar H. Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. J.Invest. Dermatol. 2000, 114:328-333.
22. Kim S.H., Henry E.C., Kim D.K., Kim Y.H., Shin K.J., Han M.S., Lee T.G., Kang J.K., Gasiewicz T.A., Ryu S.H., Suh P.G. Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol. Pharmacol. 2006, 69:1871-1878.
23. Kiss E.A., Vonarbourg C., Kopfmann S., Hobeika E., Finke D., Esser C., Diefenbach A. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011, 334:1561-1565.
24. Lee J.S., Cella M., McDonald K.G., Garlanda C., Kennedy G.D., Nukaya M., Mantovani A., Kopan R., Bradfield C.A., Newberry R.D., Colonna M. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 2012, 13:144-151.
25. Li Y., Innocentin S., Withers D.R., Roberts N.A., Gallagher A.R., Grigorieva E.F., Wilhelm C., Veldhoen M. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 2011, 147:629-640.
26. Lowes M.A., Russell C.B., Martin D.A., Towne J.E., Krueger J.G. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol. 2013, 34:174-181.
27. Martin B., Hirota K., Cua D.J., Stockinger B., Veldhoen M. Interleukin-17-producing gammadelta Tcells selectively expand in response to pathogen products and environmental signals. Immunity 2009, 31:321-330.
28. McMillan B.J., Bradfield C.A. The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems. Mol. Pharmacol. 2007, 72:487-498.
29. Mitchell K.A., Elferink C.J. Timing is everything: consequences of transient and sustained AhR activity. Biochem. Pharmacol. 2009, 77:947-956.
30. Nestle F.O., Conrad C., Tun-Kyi A., Homey B., Gombert M., Boyman O., Burg G., Liu Y.J., Gilliet M. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J.Exp. Med. 2005, 202:135-143.
31. Nestle F.O., Kaplan D.H., Barker J. Psoriasis. N.Engl. J. Med. 2009, 361:496-509.
32. Nguyen N.T., Kimura A., Nakahama T., Chinen I., Masuda K., Nohara K., Fujii-Kuriyama Y., Kishimoto T. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc. Natl. Acad. Sci. USA 2010, 107:19961-19966.
33. Pantelyushin S., Haak S., Ingold B., Kulig P., Heppner F.L., Navarini A.A., Becher B. Rorγt+ innate lymphocytes and γδ Tcells initiate psoriasiform plaque formation in mice. J.Clin. Invest. 2012, 122:2252-2256.
34. Qiu J., Heller J.J., Guo X., Chen Z.M., Fish K., Fu Y.X., Zhou L. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 2012, 36:92-104.
35. Rannug A., Fritsche E. The aryl hydrocarbon receptor and light. Biol. Chem. 2006, 387:1149-1157.
36. Swindell W.R., Johnston A., Carbajal S., Han G., Wohn C., Lu J., Xing X., Nair R.P., Voorhees J.J., Elder J.T., et al. Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS ONE 2011, 6:e18266.
37. Swindell W.R., Johnston A., Voorhees J.J., Elder J.T., Gudjonsson J.E. Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients. BMC Genomics 2013, 14:527.
38. Tagami H. Triggering factors. Clin. Dermatol. 1997, 15:677-685.
39. Tauchi M., Hida A., Negishi T., Katsuoka F., Noda S., Mimura J., Hosoya T., Yanaka A., Aburatani H., Fujii-Kuriyama Y., et al. Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions. Mol. Cell. Biol. 2005, 25:9360-9368.
40. Tian S., Krueger J.G., Li K., Jabbari A., Brodmerkel C., Lowes M.A., Suárez-Fariñas M. Meta-analysis derived (MAD) transcriptome of psoriasis defines the "core" pathogenesis of disease. PLoS ONE 2012, 7:e44274.
41. Tseng H.C., Lee I.T., Lin C.C., Chi P.L., Cheng S.E., Shih R.H., Hsiao L.D., Yang C.M. IL-1β promotes corneal epithelial cell migration by increasing MMP-9 expression through NF-κB- and AP-1-dependent pathways. PLoS ONE 2013, 8:e57955.
42. Tsoi L.C., Spain S.L., Knight J., Ellinghaus E., Stuart P.E., Capon F., Ding J., Li Y., Tejasvi T., Gudjonsson J.E., et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 2012, 44:1341-1348. Collaborative Association Study of Psoriasis (CASP), Genetic Analysis of Psoriasis ConsortiumGenetic Analysis of Psoriasis Consortium, Psoriasis Association Genetics ExtensionPsoriasis Association Genetics Extension, Wellcome Trust Case Control Consortium 2Wellcome Trust Case Control Consortium 2.
43. Van Belle A.B., de Heusch M., Lemaire M.M., Hendrickx E., Warnier G., Dunussi-Joannopoulos K., Fouser L.A., Renauld J.C., Dumoutier L. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J.Immunol. 2012, 188:462-469.
44. van den Bogaard E.H., Bergboer J.G., Vonk-Bergers M., van Vlijmen-Willems I.M., Hato S.V., van der Valk P.G., Schröder J.M., Joosten I., Zeeuwen P.L., Schalkwijk J. Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. J.Clin. Invest. 2013, 123:917-927.
45. van der Fits L., Mourits S., Voerman J.S., Kant M., Boon L., Laman J.D., Cornelissen F., Mus A.M., Florencia E., Prens E.P., Lubberts E. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J.Immunol. 2009, 182:5836-5845.
46. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., Stockinger B. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453:106-109.
47. Walter A., Schäfer M., Cecconi V., Matter C., Urosevic-Maiwald M., Belloni B., Schönewolf N., Dummer R., Bloch W., Werner S., et al. Aldara activates TLR7-independent immune defence. Nat. Commun. 2013, 4:1560.
48. Wang A., Al-Kuhlani M., Johnston S.C., Ojcius D.M., Chou J., Dean D. Transcription factor complex AP-1 mediates inflammation initiated by Chlamydia pneumoniae infection. Cell. Microbiol. 2013, 15:779-794.
49. Wincent E., Amini N., Luecke S., Glatt H., Bergman J., Crescenzi C., Rannug A., Rannug U. The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2-b]carbazole is present in humans. J.Biol. Chem. 2009, 284:2690-2696.
50. Wohn C., Ober-Blöbaum J.L., Haak S., Pantelyushin S., Cheong C., Zahner S.P., Onderwater S., Kant M., Weighardt H., Holzmann B., et al. Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice. Proc. Natl. Acad. Sci. USA 2013, 110:10723-10728.
51. Zenz R., Eferl R., Kenner L., Florin L., Hummerich L., Mehic D., Scheuch H., Angel P., Tschachler E., Wagner E.F. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005, 437:369-375.